PROTTER, ANDREW A.,RICHER, JENNIFER,COCHRANE, DAWN
申请号：
CA2843417
公开号：
CA2843417C
申请日:
2012.07.27
申请国别(地区):
CA
年份:
2018
代理人:
摘要：
The disclosure describes the use of one or more compounds that fall within the scope of one or more of structural formulae I, II, III, IV, V, or VI for treating triple negative breast Compounds useful for treating breast cancer include those compounds of formulae I, II, III, IV, V, or VI that inhibit proliferation of breast cancer cells and/or lead to the death of breast cancer cells, especially triple negative breast cancer.
